Agios Pharmaceuticals Inc (AGIO)

09:39 AM

Agios (AGIO) Unveils Promising Mitapivat Data at ASH 2025 - GuruFocus

09:39 AM

09:01 AM

Agios (Nasdaq: AGIO) shows mitapivat data: 77.8% alpha-thal response; 30.5-week mean - Stock Titan

09:01 AM

06:41 AM

Will Agios Pharmaceuticals Inc. benefit from macro trendsJuly 2025 Volume & Fast Gaining Stock Reports - newser.com

06:41 AM

05:44 AM

How supply chain issues affect Agios Pharmaceuticals Inc. stockJuly 2025 Drop Watch & AI Optimized Trading Strategy Guides - newser.com

05:44 AM

05:01 AM

Is Agios Pharmaceuticals Inc. building a consolidation basePortfolio Risk Report & AI Driven Stock Movement Reports - newser.com

05:01 AM

03:51 AM

How Agios Pharmaceuticals Inc. (8AP) stock correlates with oil marketsEntry Point & AI Powered Market Entry Ideas - newser.com

03:51 AM

02:29 AM

What is HC Wainwright's Estimate for AGIO FY2025 Earnings? - MarketBeat

02:29 AM

02:00 AM

What earnings revisions data tells us about Agios Pharmaceuticals Inc.Entry Point & Smart Investment Allocation Insights - newser.com

02:00 AM

12:28 PM

Is it time to cut losses on Agios Pharmaceuticals Inc.Inflation Watch & Breakout Confirmation Alerts - newser.com

12:28 PM

Nov 02, 2025

Can Agios Pharmaceuticals Inc. stock deliver sustainable ROERate Hike & Daily Stock Trend Reports - newser.com

Nov 02, 2025

Nov 02, 2025

What drives Agios Pharmaceuticals Inc stock priceMarket Capitalization Trends & High Return Capital Strategies - earlytimes.in

Nov 02, 2025

Nov 02, 2025

Published on: 2025-10-21 20:21:19 - earlytimes.in

Nov 02, 2025

Nov 02, 2025

Is Agios Pharmaceuticals Inc. (8AP) stock among top earnings playsMarket Volume Summary & Safe Capital Growth Trade Ideas - newser.com

Nov 02, 2025

Nov 02, 2025

Is Agios Pharmaceuticals Inc. stock supported by strong cash flowsStop Loss & Weekly High Return Opportunities - newser.com

Nov 02, 2025

Nov 02, 2025

Institutional scanner results for Agios Pharmaceuticals Inc.Bond Market & Weekly Chart Analysis and Trade Guides - newser.com

Nov 02, 2025

Nov 02, 2025

What data driven models say about Agios Pharmaceuticals Inc.’s future - newser.com

Nov 02, 2025

Nov 02, 2025

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 02, 2025

Nov 02, 2025

Savvy Advisors Inc. Takes Position in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat

Nov 02, 2025

Nov 02, 2025

Published on: 2025-11-02 02:45:06 - newser.com

Nov 02, 2025

Nov 02, 2025

Candlestick signals on Agios Pharmaceuticals Inc. stock todayQuarterly Market Summary & Reliable Price Action Trade Plans - newser.com

Nov 02, 2025

Nov 01, 2025

Agios Pharmaceuticals Q3 2025 Earnings Preview - MSN

Nov 01, 2025

Nov 01, 2025

Agios outlines Q4 2025 PYRUKYND milestones and anticipates U.S. thalassemia approval amid global expansion - MSN

Nov 01, 2025

Nov 01, 2025

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 01, 2025

Nov 01, 2025

RBC Capital Keeps Their Buy Rating on Agios Pharma (AGIO) - The Globe and Mail

Nov 01, 2025

Nov 01, 2025

Published on: 2025-11-01 04:26:21 - newser.com

Nov 01, 2025

Nov 01, 2025

Agios Pharmaceuticals’ Earnings Call: Growth and Challenges - MSN

Nov 01, 2025

Oct 31, 2025

AGIO's Q3 Loss Narrower Than Expected, Pyrukynd Drives Y/Y Revenues - sharewise.com

Oct 31, 2025

Oct 31, 2025

Agios Pharmaceuticals (NASDAQ:AGIO) Issues Quarterly Earnings Results, Beats Expectations By $0.15 EPS - MarketBeat

Oct 31, 2025

Oct 31, 2025

High Growth Tech Stocks In The US Market With Promising Potential - simplywall.st

Oct 31, 2025

Oct 31, 2025

Can Agios Pharmaceuticals Inc. stock surprise with earnings upsideGap Down & Comprehensive Market Scan Reports - newser.com

Oct 31, 2025